Proteases as next-generation therapeutics for influenza A

Sridharan is currently working in the laboratory of Dr David Baker at the University of Washington, Seattle. During his Fellowship, he aims to develop computational protocols for designing proteases with strict and defined specificity, using haemagglutinin of influenza A as a case study. The project involves collaborations to elucidate the biochemical and structural aspects of the computationally designed proteases.